国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2012年
3期
217-219
,共3页
雷娜%张博%裴迎霞%祁鑫%王金华%张芸%刘瑞%李杰%林洪生
雷娜%張博%裴迎霞%祁鑫%王金華%張蕓%劉瑞%李傑%林洪生
뢰나%장박%배영하%기흠%왕금화%장예%류서%리걸%림홍생
复方苦参注射液%smmc-7721细胞%细胞凋亡
複方苦參註射液%smmc-7721細胞%細胞凋亡
복방고삼주사액%smmc-7721세포%세포조망
Compound matrine injection%smmc-7721 cells%Cell apoptosis
目的 探究复方苦参注射液对人肝癌SMMC-7721细胞凋亡的影响.方法 无菌培养人肝癌细胞SMMC-7721,采用MTT法检测复方苦参注射液对SMMC7721细胞的影响,复方苦参注射液的浓度分别为3.34、2.38、1.43和0.48 mg/ml;采用膜联蛋白V-异硫氰酸荧光素(Annexin V-FITC)/碘化丙啶(propidium iodide,PI)双染法测肝癌细胞凋亡率,复方苦参注射液的浓度分别为0.86、1.72和3.43 mg/ml.结果 复方苦参注射液浓度3.34、2.38、1.43、0.48 mg/ml作用于SMMC-7721 24 h的细胞抑制率分别为51.03%、53.67%、49.83%、0.03%;作用48 h后,上述浓度的细胞抑制率分别为67.14%、65.35%、62.25%、0.05%,作用72 h后,分别为74.16%、68.77%、66.04%、26.02%.结果 复方苦参注射液浓度0.86、1.72和3.43 mg/ml作用于SMMC-7721 24 h的细胞凋亡率分别为(2.86±0.35)%、(15.16±1.15)%、(13.17±0.40)%;作用48 h后,上述浓度的细胞凋亡率分别为(8.57±0.44)%、(28.07±0.76)%、(29.81±8.10)%,均高于空白对照组(1.05±0.09)%(P<0.05).结论 复方苦参注射液对人肝癌SMMC-7721细胞增殖具有抑制作用,其作用机制与诱导细胞凋亡有关.
目的 探究複方苦參註射液對人肝癌SMMC-7721細胞凋亡的影響.方法 無菌培養人肝癌細胞SMMC-7721,採用MTT法檢測複方苦參註射液對SMMC7721細胞的影響,複方苦參註射液的濃度分彆為3.34、2.38、1.43和0.48 mg/ml;採用膜聯蛋白V-異硫氰痠熒光素(Annexin V-FITC)/碘化丙啶(propidium iodide,PI)雙染法測肝癌細胞凋亡率,複方苦參註射液的濃度分彆為0.86、1.72和3.43 mg/ml.結果 複方苦參註射液濃度3.34、2.38、1.43、0.48 mg/ml作用于SMMC-7721 24 h的細胞抑製率分彆為51.03%、53.67%、49.83%、0.03%;作用48 h後,上述濃度的細胞抑製率分彆為67.14%、65.35%、62.25%、0.05%,作用72 h後,分彆為74.16%、68.77%、66.04%、26.02%.結果 複方苦參註射液濃度0.86、1.72和3.43 mg/ml作用于SMMC-7721 24 h的細胞凋亡率分彆為(2.86±0.35)%、(15.16±1.15)%、(13.17±0.40)%;作用48 h後,上述濃度的細胞凋亡率分彆為(8.57±0.44)%、(28.07±0.76)%、(29.81±8.10)%,均高于空白對照組(1.05±0.09)%(P<0.05).結論 複方苦參註射液對人肝癌SMMC-7721細胞增殖具有抑製作用,其作用機製與誘導細胞凋亡有關.
목적 탐구복방고삼주사액대인간암SMMC-7721세포조망적영향.방법 무균배양인간암세포SMMC-7721,채용MTT법검측복방고삼주사액대SMMC7721세포적영향,복방고삼주사액적농도분별위3.34、2.38、1.43화0.48 mg/ml;채용막련단백V-이류청산형광소(Annexin V-FITC)/전화병정(propidium iodide,PI)쌍염법측간암세포조망솔,복방고삼주사액적농도분별위0.86、1.72화3.43 mg/ml.결과 복방고삼주사액농도3.34、2.38、1.43、0.48 mg/ml작용우SMMC-7721 24 h적세포억제솔분별위51.03%、53.67%、49.83%、0.03%;작용48 h후,상술농도적세포억제솔분별위67.14%、65.35%、62.25%、0.05%,작용72 h후,분별위74.16%、68.77%、66.04%、26.02%.결과 복방고삼주사액농도0.86、1.72화3.43 mg/ml작용우SMMC-7721 24 h적세포조망솔분별위(2.86±0.35)%、(15.16±1.15)%、(13.17±0.40)%;작용48 h후,상술농도적세포조망솔분별위(8.57±0.44)%、(28.07±0.76)%、(29.81±8.10)%,균고우공백대조조(1.05±0.09)%(P<0.05).결론 복방고삼주사액대인간암SMMC-7721세포증식구유억제작용,기작용궤제여유도세포조망유관.
Objective To explore the compound matrine injection on human hepatoma smmc-7721 cells' proliferation.Methods Human hepatoma smmc-7721 cells were sterilely cultured.Assayed the effects of compound matrine injection on smmc-7721 cells by MTT.The concentrations of the compound matrine injection were 3.34,2.38,1.43 and 0.48 mg/ml; Used the double staining method of annexin V-fluorescein isothiocyanate(Annexin V-FITC)/propidium iodide (propidium iodide,PI) to measure the apoptosis of hepatoma cell.The concentrations of the compound matrine injection were 0.86,1.72,and 3.43 mg/ml.Results The apoptosis rates of compound matrine injection with different concentration of 3.34,2.38,1.43 and 0.48 mg/ml on liver cancer cell SMMC-7721 were51.03%、53.67%、49.83% and 0.03% respectively after 24 hours; and 67.14%、65.35%、62.25% and 0.05% respectively after 48 hours;and 74.16%、68.77%、66.04% and 26.02%respectively after 72 hours.The apoptosis rates of compound matrine injection with different concentration of 0.86,1.72 and 3.43 mg/ml on liver cancer cell SMMC-7721 were(2.86±0.35)%,(15.16± 1.15)%and(13.17±0.40)% respectively after 24 hours; and (8.57±0.44)%,(28.07±0.76)% and (29.81±8.10)%respectively after 48 hours,which were significantly higher than the control group (1.05±0.09)%(P<0.05).Conclusion The compound matrine injection has a significant inhibition on human hepatoma smmc-7721 cells' proliferation and the mechanism was its inducing cell apoptosis.